Status:
RECRUITING
Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates
Lead Sponsor:
Hackensack Meridian Health
Conditions:
Pre-Term
Respiratory Distress of Newborn
Eligibility:
All Genders
34-36 years
Brief Summary
Respiratory morbidity presents a significant clinical challenge in the neonatal period, and an individual patient's clinical course is often difficult to predict. This is especially true for late-pret...
Detailed Description
Respiratory morbidity presents a significant clinical challenge in the neonatal period, and an individual patient's clinical course is often difficult to predict. This is especially true for late-pret...
Eligibility Criteria
Inclusion
- Inborn infants born between 34w0d and 36w6d gestational age
- In RA or 1 Litre per minute 1LPM NC (room air (RA) or nasal cannula (NC))
- Admitted to NICU or Well Baby Nursery (WBN)
Exclusion
- Patients born \<34 weeks or \>36w6d
- Major genetic anomaly or syndromic condition
- Cardiac or pulmonary structural defects
- Cord pH \<7.0 or 5 minute APGAR 5 or less
- Suspected fetal hemorrhage or other source of significant anemia at birth
Key Trial Info
Start Date :
November 6 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07216053
Start Date
November 6 2025
End Date
November 1 2027
Last Update
November 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack Univeristy Medical Center
Hackensack, New Jersey, United States, 07601